|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0375 - 0.0375|
|52 Week Range||0.0310 - 0.0770|
|Beta (3Y Monthly)||0.63|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
IRVINE, CA, March 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that today it has launched the selection and appointment process for the Company’s iCannabinoid Ambassador’s Program. One of the most important components of Cannabis Science’s growth and international market penetration strategy is information and the power of the people! The iCannabinoid Ambassador’s Program is expected to help Cannabis Science rapidly expand the Company’s footprint and support the development of new initiatives in new markets. Each iCannabinoid Ambassador will be designated an area of interest and expertise, based on your experience, expertise, and desired level of commitment.
Vancouver, British Columbia--(Newsfile Corp. - March 1, 2019) - Cannabis One Holdings (CSE:CBIS) is one of the latest new listing on the Canadian Securities Exchange, having previously traded on the TSX Venture Exchange as Metropolitan Energy Corp., prior to a reverse takeover.For more information, please view the InvestmentPitch Media "video" which provides additional information on the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Cannabis One" in the search box.Cannot ...
IRVINE, CA, Feb. 25, 2019 -- Pre-Clinical Work and Animal Studies Underway, and Protocols for Clinical Studies Under Development via NEWMEDIAWIRE -- Cannabis Science,.
IRVINE, CA, Feb. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that it has received an incredible response from shareholders registering for RCD Personal Shareholder Loyalty Gift. Mr. Raymond C. Dabney is CBIS’ President, CEO, and Co-founder. Registration for the Shareholder Loyalty Gift closed on January 31, 2019, and over 3,500 CBIS shareholders applied and processed via the Company’s portal.
As we've seen over the past couple of months, several countries, including the United States, passed positive legislation in favor of the legalization of cannabis. As we continue to move through this new year, the hopes are that the cannabis industry will be able to see even more gains in the future. Biome Grow Inc (CSE:BIO) (BIOIF) (6OTA.F), Pyxus International Inc (PYX), United Cannabis Corporation (CNAB), and Cannabis Science Inc (OTC PINK: CBIS) are four cannabis companies determined to champion products and services designed with the consumer in mind.
“We recently announced an extension of the date to register for my Personal Shareholder Loyalty Gift through January 31, 2019, and again, the response has been magnificently overwhelming! We are getting everything, and we are compiling and tracking the information until we can respond. Given the sheer number of registrations and questions we’ve received on this matter, coupled with the rest of our inquiries, it only makes sense to commit to an interactive online information platform such as www.Twitter.com, www.Facebook.com, www.Linkedin.com, or www.Instagram.com, obviously our platform of choice to communicate would be the recently-launched www.iCannabinoid.com platform.
IRVINE, CA, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces it is receiving an overwhelming response from shareholders registering for Mr. Raymond C. Dabney’s (RCD) Personal Shareholder Loyalty Gift. The Company recently announced it re-opened the Shareholder Loyalty Portal through January 31, 2019, and nearly 2,000 shareholder registrations have already been received by CBIS since the first week of January.
IRVINE, CA, Dec. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, applauds the U.S. Congress’ passage of the 2018 Farm Bill legalizing the production of hemp, and RCD welcomes all shareholders to the Loyalty gift final. “Cannabis Science has a number of significant developments in 2018 to celebrate, we are very excited to report our progress, and announce some outstanding surprises! Our Black-Tie Gala will be just that, a Black-Tie Celebration Gala,” stated Mr. Dabney.
CORAL GABLES, FL / ACCESSWIRE / December 13, 2018 / In the latest series of marijuana stock news the main focus has been on the 2018 US Farm Bill but what may be next is the focus on what is to come for 2019. David Goldstein, with the cannabis information company Potbotics, said 2018 was a ''huge year for marijuana. "From a Schedule One drug that says marijuana has zero health benefits.
IRVINE, CA, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the inaugural CBIS Black-tie Gala has morphed into the Cannabis Science Awards Black-Tie Gala Ceremony that it should be. The Company is excited to commit to announcing the final list of events, venues, dates and times before the end of this year. Through its Black-Tie Awards Gala, Cannabis Science intends to celebrate the Company’s accomplishments in the medical-cannabis industry, along with those who have been instrumental in the Company’s achievements, namely its many partners, individuals and companies, its shareholders and key industry individuals are slated receive the Awards.